Reaction
Cytomegalovirus Syndrome reporting signals
As of the last recalculation, Cytomegalovirus Syndrome appears in 162 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 1,003.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 60 | 1,003.2 | 1,008.2 |
| Valganciclovir | 72 | 882.4 | 885.8 |
| Valganciclovir Hydrochloride | 72 | 882.4 | 885.8 |
| Ganciclovir | 45 | 781.8 | 785.3 |
| Ganciclovir Sodium | 46 | 779.5 | 783.0 |
| Tacrolimus Ointment 0.1% | 82 | 170.3 | 170.4 |
| Tacrolimus Extended-Release Capsules | 82 | 169.8 | 169.9 |
| Basiliximab | 14 | 167.3 | 167.5 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 99.2 | 99.3 |
| Mycophenilic Acid | 14 | 94.9 | 95.0 |
| Sirolimus | 8 | 80.2 | 80.3 |
| Bendamustine Hcl | 8 | 69.7 | 69.7 |